☆ 4.5 Article

CYP3A422 may increase bleeding risk in ticagrelor users

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2023)

Get Full Text
Add to Collection

Journal

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Volume 133, Issue 2, Pages 202-207

Publisher

WILEY
DOI: 10.1111/bcpt.13884

Keywords

adverse drug events; antiplatelet drugs; ischemic heart disease; pharmacogenetics; polymorphism; precision medicine

Categories

Pharmacology & Pharmacy Toxicology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.